HLB Group Chairman Jin Yanggon Buys Stake in HLB Genex
Jin Yang-gon, chairman of HLB Group, has begun buying shares in HLB Genex.
According to HLB Group, Epoke, a financial investment company in which Chairman Jin holds a 99% stake, purchased 207,897 HLB Genex shares on the market from October 6 to 14. Following the purchases, Epoke's holdings in HLB Genex increased from 326,583 shares to 534,480 shares.
Earlier, Epoke purchased 218,718 HLB Innovation shares and 130,584 HLB Therapeutics shares on the market, respectively, from September 23 to October 1.
Chairman Jin has also continued to buy shares in his own name. Since the beginning of this year, he has purchased a total of 1,224,029 shares on the market across six affiliates: HLB Innovation, HLB Panagene, HLB Therapeutics, HLB Genex, HLB Biostep, and HLB Pep.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
An HLB Group official said, "Chairman Jin's sustained and repeated share purchases demonstrate through direct investment his confidence in the future growth of the group and its affiliates. They reflect his commitment to supporting the affiliates' growth from a long-term perspective, strengthening responsible management, and increasing both corporate and shareholder value."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
